Early multidrug treatment of SARS-CoV-2 (COVID-19) and decreased case fatality rates in Honduras

Ivermectin study #106 of 113 Meta Analysis

7/25 Early treatment study

Ontai et al., medRxiv, doi:10.1101/2021.07.21.21260223 (Preprint)
Early multidrug treatment of SARS-CoV-2 (COVID-19) and decreased case fatality rates in Honduras

Source PDF Share Tweet

Report on the nationwide implementation of multi-drug COVID-19 inpatient and outpatient treatment protocols in Honduras, showing a case fatality rate decrease from 9.33% to 2.97%. No decrease was seen in Mexico, a similar Latin American country that did not introduce multi-drug treatment protocols at that time. Decreases in COVID-19 case fatality rates in Honduras were associated with both the initial publication of the protocol and a subsequent outreach program. Both inpatient and outpatient protocols include ivermectin as one component.

Ontai et al., 7/25/2021, preprint, 6 authors.

All 113 studies Meta Analysis

Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC.

Submit